Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of ventricular tachycardia ablation in S-ICD recipients: insights from the multicenter iSUSI registry

Autor: M Schiavone, A Gasperetti, J Vogler, M Laredo, A Breitenstein, P Compagnucci, M Ziacchi, C Lavalle, P Palmisano, A Dello Russo, L Di Biase, C Tondo, J Kuschyk, R Tilz, G B Forleo

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: None. Background The recent PARTITA trial showed a net clinical benefit of early ventricular tachycardia (VT) ablation in patients with implantable cardioverter defibrillator (ICD) experiencing approp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::abd453973635d60a8df2fcca5955b393
https://doi.org/10.1093/europace/euad122.322

Zobrazit plný text záznamu

Capsulectomy: a safe and effective way to lower shock impedance in S-ICD replacement procedures

Autor: S Wuerfel, F Fastenrath, V Liebe, I Akin, M Borggrefe, D Duerschmied, J Kuschyk, B Rudic

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: None. Background The safety and efficacy of the subcutaneous implantable cardioverter-defibrillator (S-ICD) has been proven in various clinical trials. Due to intermuscular device placement, higher sh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d3696b274558079c3600ab9704d259e
https://doi.org/10.1093/europace/euad122.422

Zobrazit plný text záznamu

Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up

Autor: J A De Veld, P P H M Delnoy, L R A Olde Nordkamp, J Kuschyk, H Bonnemeier, N R Bijsterveld, L V A Boersma, M F El Chami, L Smeding, A Weger, S Richter, T R Betts, D J Wright, A A M Wilde, R E Knops

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Boston Scientific Medical device company St. Paul, Minnesota, USA Introduction The PRAETORIAN trial showed that the subcutaneous implantabl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d996cf6f0ed400f011e3fcac6cd2465
https://doi.org/10.1093/europace/euad122.427

Zobrazit plný text záznamu

Novel clinical data on cardiac contractility modulation in NYHA II patients – Results from the MAINTAINED Observational Study

Autor: C Fastner, G Yuecel, S Hetjens, B Rudic, G Schmiel, M Toepel, V Liebe, M Kruska, M Borggrefe, D Burkhoff, I Akin, D Duerschmied, J Kuschyk

Publikováno v: European Heart Journal. 43

Background Cardiac contractility modulation (CCM) is an FDA-approved device therapy for patients with medication refractory systolic heart failure and normal QRS width. Pivotal trials have been performed primarily in patients with advanced heart fail

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0499baa0b92909a0f6a2fa9acd73abe9
https://doi.org/10.1093/eurheartj/ehac544.1027

Zobrazit plný text záznamu

The subcutaneous defibrillator in patients with low BMI - insights from a large European multicenter registry

Autor: J Vogler, A Gasperetti, M Schiavone, A Breitenstein, M Laredo, P Palmisano, G Mitacchione, S Hakmi, D Ricciardi, R Arosio, M Casella, J Kuschyk, M Biffi, GB Forleo, RR Tilz

Publikováno v: EP Europace. 24

Funding Acknowledgements Type of funding sources: None. Background The subcutaneous implantable cardioverter defibrillator (S-ICD) has become an alternative to transvenous ICDs (tv-ICD), especially in young patients without a need for pacing. One of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0c90912705ac9418bcb175f108ee0a4
https://doi.org/10.1093/europace/euac053.466

Zobrazit plný text záznamu

Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence

Autor: S Pepplinkhuizen, PPHM Delnoy, LRA Olde Nordkamp, J Kuschyk, H Bonnemeier, NR Bijsterveld, LVA Boersma, MF El-Chami, L Smeding, W Van Der Stuijt, A De Weger, S Richter, TR Betts, AAM Wilde, RE Knops

Publikováno v: EP Europace. 24

Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Boston Scientific Corporation Background The PRAETORIAN trial demonstrated that the subcutaneous ICD (S-ICD) is non-inferior to the transvenous ICD (TV-ICD) wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9af46c42bf5539b304c9d6d87925526f
https://doi.org/10.1093/europace/euac053.473

Zobrazit plný text záznamu

Autor: M Schiavone, A Gasperetti, S Gulletta, J Steffel, L Kaiser, G Mitacchione, C Lavalle, N Badenco, A Dello Russo, I Olivotto, C Tondo, J Kuschyk, M Biffi, R Tilz, GB Forleo

Publikováno v: EP Europace. 24

Funding Acknowledgements Type of funding sources: None. Background Young patients often represent the most suitable candidates for an entirely subcutaenous implantable cardioverter defibrillator (S-ICD) system, since they have to face a lifetime of d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e34f9b896fc57b19f10112e14916ef2
https://doi.org/10.1093/europace/euac053.446

Zobrazit plný text záznamu

P25 SUBCUTANEOUS–ICD IN PATIENTS WITH HEART FAILURE: RESULTS FROM A MULTICENTER, EUROPEAN ANALYSIS

Publikováno v: European Heart Journal Supplements. 24

Background Data on patients with heart failure (HF) with a subcutaneous implantable cardioverter defibrillator (S–ICD) are scarce. Objective Aim of this study was to assess clinical outcomes of the S–ICD in HF patients in a real–world analysis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e70c912ef937b1366a9ba3f5b6b5ea3
https://doi.org/10.1093/eurheartj/suac012.023

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání